Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to evaluate the safety and the therapeutic activity of the combination of Natural Gel combination and hair mask of plant origin in patients with mild to moderate plaque psoriasis.


Clinical Trial Description

This is a random, double blind placebo -vehicle- controlled study. Patients recruiting and inclusion into the study is well defined. Expert on site monitoring will assure execution of all assignments as detailed in the protocol (screening, consent form, double-blind group assignment) .

Statistical analysis:

- It is calculated that 52 patients will be needed for this study.

- Type I error probability associated with this test is 0.05 .

- Uncorrected chi square will be used to assess changes in the measured variables. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02330237
Study type Interventional
Source Secret of Youth
Contact
Status Completed
Phase Phase 2/Phase 3
Start date January 2015
Completion date September 2017

See also
  Status Clinical Trial Phase
Terminated NCT02502188 - Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis Phase 1
Completed NCT00106847 - A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis Phase 3
Terminated NCT00322296 - Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis Phase 2
Completed NCT02425826 - A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. Phase 4